West Paces Advisors Inc. Kodiak Sciences Inc. Transaction History
West Paces Advisors Inc.
- $408 Billion
- Q3 2024
A detailed history of West Paces Advisors Inc. transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, West Paces Advisors Inc. holds 12 shares of KOD stock, worth $119. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12
Previous 12
-0.0%
Holding current value
$119
Previous $28,000
10.71%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding KOD
# of Institutions
98Shares Held
39MCall Options Held
6.5KPut Options Held
5.8K-
Baker Bros. Advisors LP New York, NY17.3MShares$173 Million0.48% of portfolio
-
Black Rock Inc. New York, NY3.85MShares$38.4 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.95MShares$19.5 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.69MShares$16.8 Million0.0% of portfolio
-
Iconiq Capital, LLC San Francisco, CA1.02MShares$10.1 Million0.06% of portfolio
About Kodiak Sciences Inc.
- Ticker KOD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,040,200
- Market Cap $519M
- Description
- Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...